| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |